Event-Driven Stocks

Innoveren Scientific, Inc.

Healthcare · Surgical & Medical Instruments & Apparatus · NV · SEC filings ↗ · Compare ⊕

Signs● 2 good● 5 warning● 3 severedetails ↓

Financials

SEC XBRL · annual
 FY22FY21FY20FY19FY18FY17
Revenue$453,460$1.6M$2.2M$8.3M$7.9M$207,344
Operating income−$5.1M−$5.3M−$7.1M−$30.6M−$4.2M−$6.1M
Net income−$10.3M−$4.8M−$6.5M−$29.8M−$4.4M−$6.5M
Total assets$137,357$321,405$2.2M$3.3M$454,896$1.2M
Total liabilities$9.5M$5.0M$3.3M$6.7M$6.5M$514,732
Equity−$9.4M−$4.7M−$1.0M−$9.5M−$2.0M$713,421
EPS (diluted)$-35.06$-32.93————
Shares out.245.1M136.1M99.9M90.2M21.9M17.0M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2022
Operating margin
−1126.0%
Net margin
−2271.3%
Return on equity
110.1%
Return on assets
−7498.4%
Return on capital (ROCE)
—
Liabilities / assets
6912.5%
Debt / equity
—
Book value / share
$-0.04
Revenue growth (YoY)
−71.9%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2022
Altman Z″ (distress)
-2011.99distress
Accruals / assets
−6105.1%clean
Piotroski F-Score
1/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
32
/ 100
Profitability 25Growth 0Catalyst 67Earnings quality 67Financial strength 0

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 3 severe● 5 warning● 2 good
  • Negative shareholder equity
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue declined year-over-year
  • High leverage (liabilities > 70% of assets)
  • Negative operating cash flow
  • Strong return on equity (>15%)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.